Tempus AI ROE 2023-2025 | TEM

Current and historical return on equity (ROE) values for Tempus AI (TEM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Tempus AI ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.72B $0.33B -540.07%
2024-12-31 $-0.75B $0.06B 235.70%
2024-09-30 $-0.78B $0.05B 115.83%
2024-06-30 $-0.77B $0.10B 111.97%
2024-03-31 $-0.28B $-1.47B 38.52%
2023-12-31 $-0.25B $-1.38B 71.78%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $12.393B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $44.935B 57.17
Doximity (DOCS) United States $11.901B 52.95
Hims & Hers Health (HIMS) United States $10.549B 87.28
IRhythm Technologies (IRTC) United States $5.208B 0.00
Hinge Health (HNGE) United States $4.462B 0.00
Privia Health (PRVA) United States $2.542B 188.27
Inspire Medical Systems (INSP) United States $2.501B 36.77
Phreesia (PHR) United States $1.667B 0.00
Enovis (ENOV) United States $1.647B 8.71
10x Genomics (TXG) United States $1.630B 0.00
Omnicell (OMCL) United States $1.446B 27.85
Schrodinger (SDGR) United States $1.427B 0.00
Azenta (AZTA) United States $1.402B 61.18
Clover Health Investments (CLOV) United States $1.317B 0.00
Claritev (CTEV) United States $1.117B 0.00
Evolent Health (EVH) United States $1.035B 0.00
Fulgent Genetics (FLGT) United States $0.665B 0.00
Zepp Health (ZEPP) Netherlands $0.509B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Standard BioTools (LAB) United States $0.463B 0.00
Talkspace (TALK) United States $0.424B 126.50
Carlsmed (CARL) $0.370B 0.00
Butterfly Network (BFLY) United States $0.355B 0.00
TruBridge (TBRG) United States $0.287B 50.40
Nyxoah SA (NYXH) Belgium $0.232B 0.00
Outset Medical (OM) United States $0.229B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.222B 0.00
Health Catalyst (HCAT) United States $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.186B 0.00
MDxHealth SA (MDXH) Belgium $0.134B 0.00
American Well (AMWL) United States $0.117B 0.00
CareCloud (CCLD) United States $0.108B 4.92
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.093B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.069B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.057B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Precipio (PRPO) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.019B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00